Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Methotrexate 5g/50ml solution for infusion vials
0801030P0AACSCS
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 5mg/0.2ml inj pre-filled syringes
0801030P0AABPBP
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 5mg/5ml oral liquid
1001030U0AAAFAF
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 6mg/5ml oral liquid
1001030U0AAAWAW
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 7.5mg/0.75ml inj pre-filled syringes
1001030U0AAAZAZ
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 750micrograms/5ml oral liquid
1001030U0AAAQAQ
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 7mg/5ml oral liquid
1001030U0AAAMAM
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 8mg/5ml oral liquid
1001030U0AAAPAP
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methoxamine 20mg/1ml solution for injection ampoules
0207020N0AAAAAA
|
Methoxamine hydrochloride | Methoxamine hydrochloride | Cardiovascular System | No data available |
|
Methoxsalen 0.005% gel
1305020L0AAAMAM
|
Methoxsalen | Methoxsalen | Skin | No data available |
|
Methoxsalen 10mg tablets
1305020L0AAAJAJ
|
Methoxsalen | Methoxsalen | Skin | No data available |
|
Methoxy polyethylene glycol-epoetin beta 100microg/0.3ml inj
0901030N0AAACAC
|
MPEG-Epoetin Beta | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
|
Methoxy polyethylene glycol-epoetin beta 200microg/0.3ml inj
0901030N0AAAEAE
|
MPEG-Epoetin Beta | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
|
Methoxy polyethylene glycol-epoetin beta 250microg/0.3ml inj
0901030N0AAAFAF
|
MPEG-Epoetin Beta | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
|
Methoxy polyethylene glycol-epoetin beta 360microg/0.6ml inj
0901030N0AAAIAI
|
MPEG-Epoetin Beta | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
|
Methoxy polyethylene glycol-epoetin beta 75microg/0.3ml inj
0901030N0AAABAB
|
MPEG-Epoetin Beta | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
|
Methycobal 500micrograms/1ml solution for injection ampoules
0901020T0BCAAAD
|
Methycobal | Mecobalamin | Nutrition and Blood | No data available |
|
Methyl aminolevulinate 16% cream
1308010X0AAAAAA
|
Methyl-5-aminolevulinate | Methyl-5-aminolevulinate | Skin | No data available |
|
Methyl nicotinate 1% cream
1314000M0AAAAAA
|
Methyl nicotinate | Methyl nicotinate | Skin | No data available |
|
Methyl salicylate 25% liniment
1003020N0AAAAAA
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Methyl salicylate 70mg/g topical solution
1003020N0AABBBB
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Methyl salicylate liquid
1003020N0AAAFAF
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Methylcellulose 100mg/5ml oral liquid
0106010H0AAAKAK
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 112.5mg/5ml oral liquid
0106010H0AAALAL
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 168.75mg/5ml oral liquid
0106010H0AAAVAV
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.